Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 979

  • The following term was ignored: -
  • See the search details.
1.

Severe aortic arch calcification predicts mortality in patients undergoing peritoneal dialysis.

Wu CF, Lee YF, Lee WJ, Su CT, Lee LJ, Wu KD, Chen PC, Kao TW.

J Formos Med Assoc. 2016 Aug 3. pii: S0929-6646(16)30114-0. doi: 10.1016/j.jfma.2016.06.006. [Epub ahead of print]

2.

Massive haemorrhage in liver transplantation: Consequences, prediction and management.

Cleland S, Corredor C, Ye JJ, Srinivas C, McCluskey SA.

World J Transplant. 2016 Jun 24;6(2):291-305. doi: 10.5500/wjt.v6.i2.291. Review.

3.

[Treatment of hypertension in chronic kidney disease].

Palomo-Piñón S, Rosas-Peralta M, Paniagua-Sierra JR.

Rev Med Inst Mex Seguro Soc. 2016;54 Suppl 1:s78-88. Spanish.

PMID:
27284847
4.

Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes.

Kim SS, Kim JH, Kim IJ.

Endocrinol Metab (Seoul). 2016 Jun;31(2):245-53. doi: 10.3803/EnM.2016.31.2.245. Epub 2016 May 27. Review.

5.

Nephrology Update: End-Stage Renal Disease and Renal Replacement Therapy.

Desai N, Rahman M.

FP Essent. 2016 May;444:23-9. Review.

PMID:
27163762
6.

Development and validation of cardiovascular risk scores for haemodialysis patients.

Anker SD, Gillespie IA, Eckardt KU, Kronenberg F, Richards S, Drueke TB, Stenvinkel P, Pisoni RL, Robinson BM, Marcelli D, Froissart M, Floege J; On behalf the ARO Steering Committee (collaborators).

Int J Cardiol. 2016 Aug 1;216:68-77. doi: 10.1016/j.ijcard.2016.04.151. Epub 2016 Apr 20.

PMID:
27140339
7.

Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.

Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, Islam N, Bravo RF, Aleckovic-Halilovic M, Zou H, Zhang L, Gouda Z, Tchokhonelidze I, Abraham G, Mahdavi-Mazdeh M, Gallieni M, Codreanu I, Togtokh A, Sharma SK, Koirala P, Uprety S, Ulasi I, Remuzzi G.

Lancet Glob Health. 2016 May;4(5):e307-19. doi: 10.1016/S2214-109X(16)00071-1.

8.

Blood pressure measurement in hemodialysis: The importance of the measurement technique.

Kubrusly M, de Oliveira CM, Silva RP, Pinheiro MA, Rocha MB, Magalhães RM.

Saudi J Kidney Dis Transpl. 2016 Mar;27(2):241-9. doi: 10.4103/1319-2442.178251.

9.

Lupus nephritis: An approach to diagnosis and treatment in South Africa.

Okpechi IG, Ameh OI.

S Afr Med J. 2015 Dec;105(12):1071-4. Review.

PMID:
26933719
10.

Platelet to Lymphocyte Percentage Ratio Is Associated With Brachial-Ankle Pulse Wave Velocity in Hemodialysis.

Chen SC, Lee MY, Huang JC, Tsai YC, Mai HC, Su HM, Chang JM, Chen HC.

Medicine (Baltimore). 2016 Feb;95(6):e2727. doi: 10.1097/MD.0000000000002727.

11.

Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.

Sarmento-Dias M, Santos-Araújo C, Poínhos R, Oliveira B, Silva IS, Silva LS, Sousa MJ, Correia F, Pestana M.

Clin Nephrol. 2016 Mar;85(3):135-41. doi: 10.5414/CN108716.

PMID:
26833300
12.

Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.

Li W, Zhang S.

Adv Clin Exp Med. 2015 Nov-Dec;24(6):1007-12. doi: 10.17219/acem/23439.

13.

Relationship between declining GFR and measures of cardiac and vascular autonomic neuropathy.

Clyne N, Hellberg M, Kouidi E, Deligiannis A, Höglund P.

Nephrology (Carlton). 2015 Dec 29. doi: 10.1111/nep.12706. [Epub ahead of print]

PMID:
26714273
14.

Strategies for Controlling Blood Pressure and Reducing Cardiovascular Disease Risk in Patients with Chronic Kidney Disease.

Norris KC, Nicholas SB.

Ethn Dis. 2015 Nov 5;25(4):515-20. doi: 10.18865/ed.25.4.515. Review.

15.

Adequacy of twice weekly hemodialysis in end stage renal disease patients at a tertiary care dialysis centre.

Chauhan R, Mendonca S.

Indian J Nephrol. 2015 Nov-Dec;25(6):329-33. doi: 10.4103/0971-4065.151762.

16.

Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.

Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C.

Cardiorenal Med. 2015 Oct;5(4):254-66. doi: 10.1159/000435838. Epub 2015 Jul 15. Review.

17.

Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease.

Rhee JJ, Ding VY, Rehkopf DH, Arce CM, Winkelmayer WC.

BMC Nephrol. 2015 Dec 9;16:204. doi: 10.1186/s12882-015-0204-4.

18.

Systemic Effects of Hemodialysis Access.

Agarwal AK.

Adv Chronic Kidney Dis. 2015 Nov;22(6):459-65. doi: 10.1053/j.ackd.2015.07.003. Review.

PMID:
26524951
19.

Risk factors for pulmonary hypertension in maintenance hemodialysis patients: a cross-sectional study.

He Y, Wang Y, Luo X, Ke J, Du Y, Li M.

Int Urol Nephrol. 2015 Nov;47(11):1889-97.

PMID:
26463080
20.

Peritoneal ultrafiltration for refractory fluid overload and ascites due to pulmonary arterial hypertension.

Husain-Syed F, Muciño-Bermejo MJ, Ronco C, Seeger W, Birk HW.

Ann Hepatol. 2015 Nov-Dec;14(6):929-32. doi: 10.5604/16652681.1171786.

PMID:
26436367
Items per page

Supplemental Content

Loading ...
Write to the Help Desk